BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Damkjær M, Suppli Ulrik C, Godtfredsen N, Håkansson KEJ. Beta-Blockers in High-Risk Outpatients with Chronic Obstructive Pulmonary Disease are Associated with All-Cause Mortality - The STATUETTE Cohort Study. Int J Chron Obstruct Pulmon Dis 2021;16:2397-406. [PMID: 34465987 DOI: 10.2147/COPD.S315151] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Lahousse L. Which COPD patients benefit from beta-blocker therapy? Trends Cardiovasc Med 2021:S1050-1738(21)00149-3. [PMID: 34929302 DOI: 10.1016/j.tcm.2021.12.005] [Reference Citation Analysis]
2 Ruzieh M, Baugh AD, Al Jebbawi L, Edwards ES, Jia KQ, Dransfield MT, Foy AJ. Beta-blocker use in patients with chronic obstructive pulmonary disease: A systematic review: A systematic review of βB in COPD. Trends Cardiovasc Med 2021:S1050-1738(21)00139-0. [PMID: 34856338 DOI: 10.1016/j.tcm.2021.11.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]